AtlantiCare First in Region to Offer Robotic Nipple-Sparing Mastectomy

AtlantiCare today announced that it is the first healthcare system in the tri-state region to offer robotic nipple-sparing mastectomy (RNSM) using the da Vinci Single Port (SP) surgical system, marking a significant advancement in breast cancer surgery and expanding options for patients seeking more minimally invasive treatment. Kay Yoon-Flannery, DO, MPH, FACS, Chief of Women’s Oncology at AtlantiCare Cancer Care Institute will perform the procedure at AtlantiCare Regional Medical Center’s Atlantic City Campus.

“Choosing to undergo a mastectomy is one of the most personal and emotional decisions a patient can face,” said Dr. Yoon-Flannery. “Introducing robotic nipple-sparing mastectomy here at AtlantiCare is a powerful step forward in helping women not only survive cancer but maintain their sense-of-self and quality of life.”

As a nationally recognized fellowship-trained breast surgeon known for her advanced techniques and patient-centered approach, Dr. Yoon-Flannery was the first breast surgeon from the United States invited to receive training on the procedure by traveling to South Korea to participate in an international robotic breast surgery observership.

Following recent FDA clearance, the da Vinci SP system may offer patients meaningful benefits, including a single, smaller incision, reduced risk of certain complications affecting skin or nipple blood flow, and the potential to preserve nipple sensation. Importantly, it may also support a more natural appearance following reconstruction, an important consideration for many patients. AtlantiCare is currently the only healthcare system in the tri-state area to offer this procedure for both cancer treatment and risk-reduction in high-risk patients.

“In the world of oncology, innovation must always be grounded in improving the patient experience,” added Dr. Yoon-Flannery. Offering this advanced procedure allows us to care for the whole person, supporting healing, confidence, and dignity and reinforcing AtlantiCare’s commitment to delivering world-class, compassionate, and cutting-edge care.

The addition of robotic nipple-sparing mastectomy further strengthens AtlantiCare’s comprehensive cancer program, which combines leading-edge technology with a multidisciplinary team approach. The AtlantiCare Women’s Oncology team integrates breast, gynecologic, and genetic cancer services into a coordinated continuum of care that spans prevention, early detection, treatment, survivorship, and support services.

The AtlantiCare Cancer Care Institute’s affiliation with Cleveland Clinic Cancer Institute brings globally recognized cancer expertise, advanced research, and access to clinical trials to patients in South Jersey. Through this collaboration, patients benefit from tumor review boards, second opinions, and innovative treatment options from world-renowned cancer specialists.

New patients please call 609-677-7797 to schedule an appointment.